- Home
- GSBC vs RGNX Comparison
GSBC vs RGNX Comparison
Compare GSBC & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSBC | RGNX |
|---|---|---|
| Founded | 1923 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 673.5M | 761.9M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GSBC | RGNX |
|---|---|---|
| Price | $62.07 | $8.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $60.50 | $29.13 |
| AVG Volume (30 Days) | 57.1K | ★ 819.3K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ 23.75 |
| EPS | ★ 4.74 | N/A |
| Revenue | N/A | ★ $10,393,000.00 |
| Revenue This Year | N/A | $127.88 |
| Revenue Next Year | $2.56 | $42.53 |
| P/E Ratio | $13.18 | ★ N/A |
| Revenue Growth | N/A | ★ 126.48 |
| 52 Week Low | $47.57 | $5.04 |
| 52 Week High | $67.70 | $16.19 |
Technical Indicators
Market Signals| Indicator | GSBC | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 39.37 |
| Support Level | $61.48 | $8.68 |
| Resistance Level | $63.44 | $9.28 |
| Average True Range (ATR) | 1.69 | 0.63 |
| MACD | -0.21 | 0.23 |
| Stochastic Oscillator | 33.97 | 55.64 |
Price Performance
Historical ComparisonAbout GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.